Physician profile
Sandy Terc
NPI 1477839165
$1,306.79
in general payments reported to CMS, 2019-2025
27 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $159 · 2023: $203 · 2024: $520 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $165.51 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.00 | 2021-2024 | Jardiance |
| Novo Nordisk INC | $138.02 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $107.59 | 2024 | Gemtesa |
| Boston Scientific Corporation | $75.41 | 2022-2024 | Varithena Administration Pack |
| Medtronic, INC. | $68.51 | 2023-2025 | Inceptiv, Linq II, Venaseal |
| Daiichi Sankyo INC. | $54.63 | 2024 | Injectafer |
| Abbvie INC. | $50.76 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $46.41 | 2024-2025 | |
| Atricure, INC. | $45.04 | 2021-2023 | |
| Smith+Nephew, INC. | $43.12 | 2022 | |
| Amgen INC. | $38.18 | 2024 | Otezla, Repatha |
| Medicomp INC | $33.07 | 2025 | Telepatch Cardiac Monitor |
| Phathom Pharmaceuticals, INC. | $30.31 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $29.45 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $22.99 | 2024 | Ibsrela |
| E.R. Squibb & Sons, L.L.C. | $21.77 | 2023 | Camzyos |
| Shield Therapeutics INC | $21.18 | 2023 | Accrufer |
| Zimmer Biomet Holdings, INC. | $21.01 | 2024 | Visco-3 Sodium Hyaluronate |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.28 | 2023 | Lifevest |
| Heartflow, INC. | $18.81 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $18.05 | 2024 | Uptravi, Opsumit |
| Exact Sciences Corporation | $17.96 | 2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $16.28 | 2021 | |
| Advanced Oxygen Therapy INC. | $14.48 | 2024 | Topical Oxygen Chamber For Extremities |
| Vistapharm, INC. | $14.28 | 2021 | |
| Hydrofera LLC | $13.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Terc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.